Provision of nonpharmacolocical treatment options for COPD patients in 13 European countries: Results from the European COPD audit
S. Hartl, J. Lopez-Campos, M. Roberts, M. Haan, R. Breyer-Kohansal, W. Jansen, N. Miculinic, N. Tzanakis, S. McCormack, J. Chorostowska, I. Solovic, F. Pozo-Rodríguez, D. Stolz, M. Polatli, S. Welham, C. Farrugia Jones, F. Mihaltan (Vienna, Austria; Seville, Madrid, Spain; London, United Kingdom; Lausanne, Basel, Switzerland; Leuven, Belgium; Zagreb, Croatia; Marsaxlo, Malta; Crete, Greece; Dublin, Ireland; Warsaw, Poland; Vysne Hagy, Slovakia; Aydin, Turkey; Bucarest, Romania)
Source: Annual Congress 2011 - COPD: integrated care and rehabilitation
Session: COPD: integrated care and rehabilitation
Session type: Oral Presentation
Number: 4869
Disease area: Airway diseases, Respiratory critical care
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Hartl, J. Lopez-Campos, M. Roberts, M. Haan, R. Breyer-Kohansal, W. Jansen, N. Miculinic, N. Tzanakis, S. McCormack, J. Chorostowska, I. Solovic, F. Pozo-Rodríguez, D. Stolz, M. Polatli, S. Welham, C. Farrugia Jones, F. Mihaltan (Vienna, Austria; Seville, Madrid, Spain; London, United Kingdom; Lausanne, Basel, Switzerland; Leuven, Belgium; Zagreb, Croatia; Marsaxlo, Malta; Crete, Greece; Dublin, Ireland; Warsaw, Poland; Vysne Hagy, Slovakia; Aydin, Turkey; Bucarest, Romania). Provision of nonpharmacolocical treatment options for COPD patients in 13 European countries: Results from the European COPD audit. Eur Respir J 2011; 38: Suppl. 55, 4869
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: